Flare Capital Partners is a leading investor dedicated to healthcare technology, partnering with entrepreneurs to improve outcomes and reduce costs. They provide strategic support and industry connections to accelerate market access and commercial validation for healthcare technology companies.

Flare Capital Partners

New England Venture Network is an organization of over 600 venture capitalists in Boston and greater New England designed to foster a vibrant and connected community in the area. The organization focuses on building relationships among peers and improving the New England technology and investment landscape in high tech, life science, and clean tech.

New England Venture Network

Flare Capital is a team of proven healthcare technology venture capital investors known for their unparalleled strategic industry resources, insight and total commitment to the success of its entrepreneurs.  Flare Capital raised one of the industry’s largest dedicated venture capital funds focused exclusively on early stage and emerging growth investments in healthcare technology innovation and is privileged to closely partner with founders and management.  Selected investments include Bright Health, Circulation, ClearDATA, HealthVerity, Iora Health, Valence Health, and Welltok, in addition to a strategic partnership with Rock Health, a leading healthcare technology incubator seed fund based in Silicon Valley.  Learn more at www.flarecapital.com.

If you missed Flare Capital Partners' recent quarterly Expert Roundtable Series “Digital Health’s Role in Cancer Care", the webinar recording is now on Vimeo ➡️ https://lnkd.in/ez3AXVMY

Make sure to mark your calendar for the next Expert Roundtable Series on Tuesday, March 19, 2024 from 12:00pm - 1:00pm EST. The session is titled "Next Frontier of the Primary Care Revolution: Focused Factories" and will explore the groundbreaking developments in primary care. 

Thank you again to all of our panelists for sharing their deep knowledge and keen insights - Rick Dean, Chief Executive Officer, OncoHealth, Hil Moss, Co-Founder and Chief Executive Officer, VivorCare, Adam Pellegrini, Co-Founder and Chief Executive Officer, Jasper Health, Alice Lin Pomponio, Managing Director, BrightEdge - American Cancer Society , Michael Sherman, MD, Venture Partner, RA Capital Management, Rasu Shrestha MD MBA, Chief Innovation and Commercialization Officer and Executive Vice President, Advocate Health, Melisa Tucker, Director of Product and Head of Research Evidence Generation Program, Verily, and Suneet Varma, Global Oncology and US President, Pfizer.

Healthtech to Address Causes of Death...
It is estimated that this year 60.8 million people will die globally. While a staggering figure, this is a marked improvement from the 69.3 million in 2021, according to data from Database.earth, which determined that as of this past weekend there were 8.078 billion people on the planet. While the causes of death are almost too numerous to count, the role innovation has played – specifically, healthcare technology – is profound and continues to promise dramatic improvements to the quality and length of life. According to Rock Health data, nearly $105 billion has been invested over the last decade in digital health companies, nearly all of which look to facilitate access to appropriate care to improve outcomes and lower costs, either directly or indirectly.
 
Technology is one of the great democratizing forces in healthcare: care can be more readily extended to historically disenfranchised populations. Dramatic and parallel advances in biotech, medtech, and healthcare technologies have ushered in a profound reduction in the death rate per 100k globally over the last twenty years, from 1,114 to 735 people. Over the last 160 years, life expectancy in the United States improved by nearly 40 years, according to data from Statisia.
 
According to the Social Security Administration’s Life Expectancy Calculator, it now appears that I have 8,212 days to live. Keep the healthcare technology advances coming…
https://lnkd.in/ekYk7JWT

Join us next Tuesday December 12th for Flare Capital Partners' Expert Roundtable 'Digital Health's Role in Cancer Care' alongside leading industry experts and top executives from pharma, payers, and employers, as well as founders creating breakthrough solutions in the space. Featured panelists include:

✔ Rick Dean, Chief Executive Officer, OncoHealth
✔ Hil Moss, Co-Founder and Chief Executive Officer, VivorCare
✔ Adam Pellegrini, Co-Founder and Chief Executive Officer, Jasper Health
✔ Alice Lin Pomponio, Managing Director, BrightEdge - American Cancer Society 
✔ Michael Sherman, MD, Venture Partner, RA Capital Management
✔ Rasu Shrestha MD MBA, Chief Innovation and Commercialization Officer and Executive Vice President, Advocate Health
✔ Melisa Tucker, Director of Product and Head of Research Evidence Generation Program, Verily
✔ Suneet Varma, Global Oncology and US President, Pfizer

🔗 Make sure to register here: https://lnkd.in/eVgzBMKs

Flare Scholar Spotlight #34 Alyssa Reisner, Principal at CVS Health Ventures.

Alyssa leads early and mid-stage investing at CVS Health Ventures focused on digital health and tech-enabled health care services. Prior to her investor role, Alyssa built and managed partnerships between CVS Health and the start-up & technology ecosystem. She is an alumnus of Babson College.

What is one area of healthcare you are excited about, and why?
“I am such a healthcare nerd it is hard to pick one, but one of the areas that gets me excited is the growing innovation in women’s health.”

What is one fun fact about yourself?
“I am a passionate migraine advocate!”

Flare Scholar Spotlight #33 Alexa Morse, Health Strategy Manager at Accenture.

Alexa is a Health Strategy Manager at Accenture, focused on growth and innovation projects across payer and provider organizations. Prior to Accenture, Alexa managed commercialization programs for early-stage health technology companies. She completed her MPH from Emory University and MBA from Georgia Tech Scheller College of Business.

What is one area of healthcare you are excited about, and why?
“I am especially excited about care delivery models that improve access to care and enhance both patient and provider experience.”

What is one fun fact about yourself?
“I have two adorable dogs, Bernie and Kenobi.”

We're excited to announce two new speakers for our Expert Roundtable Series on "Digital Health's Role in Cancer Care" this December 12th:

Suneet Varma, Global Oncology and US President, Pfizer

Melisa Tucker, Director of Product and Head of Research Evidence Generation Program, Verily

They join our impressive lineup of industry leaders ready to dive into the changing landscape of cancer care and the pivotal role of digital health in driving innovation:

Rick Dean, Chief Executive Officer, OncoHealth

Hil Moss, Co-Founder and Chief Executive Officer, VivorCare

Adam Pellegrini, Co-Founder and Chief Executive Officer, Jasper Health

Alice Lin Pomponio, Managing Director, American Cancer Society BrightEdge - American Cancer Society 

Michael Sherman, MD, Venture Partner, RA Capital Management

Rasu Shrestha MD MBA, Chief Innovation and Commercialization Officer and Executive Vice President, Advocate Health

RSVP now to secure your spot for this open event, and gain valuable insights from top executives in pharma, payers, and employers, alongside founders creating breakthrough solutions in the space. Spaces are limited, and participation is capped at 1000 attendees.

Don't miss this opportunity to learn about #DigitalHealth, #Oncology, #Innovation, and more from leading experts in the field. Feel free to share with others who might find this topic interesting.

🔗 Register here: https://lnkd.in/eVgzBMKs

Looking forward to seeing you there!

Join Flare Capital Partners (moderators: Michael A. Greeley, Dan Gebremedhin MD, MBA, and Jonathon George) alongside a virtual panel of senior healthcare executives from the Flare Capital network, as we discuss digital health’s role in the evolving landscape of cancer care.
 
Our speakers bring valuable experiences and perspectives to the topic. We will be joined by executives in pharma, payers, and employers who are evaluating vendors as potential partners, as well as founders building emerging solutions in the space. We are honored to have with us:
 
Rick Dean, Chief Executive Officer, OncoHealth 

Hil Moss, Co-Founder and Chief Executive Officer, VivorCare 

Adam Pellegrini, Co-Founder and Chief Executive Officer, Jasper Health 

Alice Lin Pomponio, Managing Director, American Cancer Society BrightEdge - American Cancer Society 

Michael Sherman, MD, Venture Partner, RA Capital Management

Rasu Shrestha MD MBA, Chief Innovation and Commercialization Officer and Executive Vice President, Advocate Health
 
*Additional speakers to be announced 
 
Through a series of fireside chats, we will take time to discuss digital health and AI’s role in oncology innovation and drug development, unpack the shift toward value-based care (VBC) and employer buying behaviors, and learn more about emerging solutions and their impact on payment model innovation.

Register here: https://lnkd.in/eVgzBMKs

Flare Scholar Spotlight #32 Jack Huang, Psychiatry Resident at Brigham and Women's Hospital; The Wharton School MD/MBA '22.

Jack is a resident physician in psychiatry at Harvard University. He completed his MD/MBA at Penn Medicine and Wharton. During COVID, he helped launch PennCOBALT, a community-based digital mental health platform. Jack also has experience advising startups and larger organizations at the intersection of mental health and healthcare technology.

What is one area of healthcare you are excited about, and why?
“I am excited about the opportunity for healthcare technology – used thoughtfully and collaboratively – to transform the delivery of mental healthcare and improve mental health at a population level.”

What is one fun fact about yourself?
“I love playing piano for karaoke and jam sessions, and was recently in a healthcare band called the The Iron Triangle.”

We had an amazing time last week at Flare Capital Partners' Scholar Day, an annual event designed to bring together our current and alumni classes of 300+ rising leaders from across the healthcare ecosystem. We continue to be impressed by the strength of the Flare Scholar community and are always excited to host this group in-person. 

A special thank you to our panelists for joining us: Joe Connolly CEO & Co-Founder, Visana Health, Brooke Boyarsky Pratt, CEO & Co-Founder, knownwell, Angela Fitch MD, FACP, FOMA, Dipl. ABOM CMO & Co-Founder, Knownwell, Varsha Rao Executive Partner, Flare Capital, Gregory Snyder, VP of Clinical Strategy & Quality Improvement at Medically Home, Tony Clapsis SVP, CVS Health, and Mark Reardon, MD MBA SVP, Market Ops Lead & Chief Quality Officer, Upstream. We hope to see you all next year!

Hospital Sector is Under Siege...
https://lnkd.in/e4urkJuV
Each year there are over 34 million admissions across the more than 6,100 hospitals in the United States. Never before has this critical healthcare infrastructure been so needed, and yet, never before has it been under such duress. The convergence of deep and profound financial pressures is crashing into workforce issues, with one exacerbating the other. Municipal Market Analytics estimates that nearly 4% of the approximately $300 billion of hospital bonds outstanding are experiencing payment difficulties. A recent Fitch Ratings analysis calculated that the median debt-to-EBITDA ratio for U.S. hospitals is approximately 3.9x, up from 2.5x in 2021.
 
A paradox: the high fixed cost structure of hospitals may work against the adoption of innovative value-based care payment models which reward hospitals to move away from, use less of traditional high margin services. There will be even greater financial pressures as more and more of the care provided will be paid for by government programs with lower reimbursement rates. Having a deeper appreciation of this will better inform entrepreneurs and investors on how best to partner with hospitals.
 
Some thoughts on how best to navigate this landscape…oh, and the possible role of generative AI, of course.
Flare Capital Partners #digitalhealth

Metric
Company Name	Flare Capital Partners	New England Venture Network
Symbol
MSH ID	COM:FLARECAPITAL	ORG:NEVN
Market	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Commercial & Professional Services
Industry	Healthcare & Health Services	Investment & Venture Capital
Country	US	US
Stage
Employee Count	80
Website	flarecapital.com	nevn.org
LinkedIn	flare-capital-partners
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	14.37
28-Day Growth Score	20.39
90-Day Growth Score	18.09
365-Day Growth Score	47.97

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:FLARECAPITAL

Flare Capital Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue